Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtrer
1.
Klin Lab Diagn ; 66(11): 661-665, 2021 Nov 29.
Article de Anglais | MEDLINE | ID: mdl-34882350

RÉSUMÉ

The frequency of AB0 and Rhesus blood groups was studied in 12120 patients with COVID-19, 5180 convalescent plasma donors and 118801 healthy donors from Moscow, Smolensk, Yakutsk, Minsk and Gomel. In infected individuals, the frequency of blood group A was significantly higher than in uninfected individuals (41,54 % and 34,39 % respectively, p<0,05), and the frequency of blood group 0, on the contrary, was significantly lower (27,69 % and 36,71 %, p<0,05). The frequency of blood group A was particularly high among patients who died from ARVI COVID-19 - 45,51 % vs. 34,39 %, p=0,008. In some groups of patients, there was a decrease in the frequency of Rh-negative individuals (2,23 % vs. 8,30 %, p<0,001).


Sujet(s)
COVID-19 , Système ABO de groupes sanguins , COVID-19/thérapie , Humains , Immunisation passive , Facteurs de risque , SARS-CoV-2 , Sérothérapie COVID-19
2.
Khirurgiia (Mosk) ; (6): 5-17, 2020.
Article de Russe | MEDLINE | ID: mdl-32573526

RÉSUMÉ

The Russian consensus document on topical issues of the diagnosis and treatment of obstructive jaundice syndrome was prepared by a group of experts in various fields of surgery, endoscopy, interventional radiology, radiological diagnosis and intensive care. The goal of this document is to clarify and consolidate the opinions of national experts on the following issues: timing of diagnosis of obstructive jaundice, features of diagnostic measures, the need and possibility of conservative measures for obstructive jaundice, and strategy of biliary decompression depending on the cause and level of biliary block.


Sujet(s)
Ictère rétentionnel/diagnostic , Ictère rétentionnel/thérapie , Consensus , Humains , Russie
3.
Article de Russe | MEDLINE | ID: mdl-29927426

RÉSUMÉ

The article describes a rare clinical case of a patient with previously undiagnosed von Willebrand disease and basal meningioma; an intracranial neurosurgical intervention was complicated by delayed intracranial hematomas, both at the resected tumor site and distantly. The diagnosis of von Willebrand disease was established only after special hematology tests and only after surgery. Despite the use of specific therapy, the patient died due to intracranial hemorrhagic complications in the postoperative period. The paper discusses the problem of preoperative diagnosis of asymptomatic hemostasis disorders in neurosurgical patients and potential ways of its solution.


Sujet(s)
Hémorragies intracrâniennes , Tumeurs des méninges , Méningiome , Maladies de von Willebrand , Humains , Complications postopératoires , Maladies de von Willebrand/complications
4.
Anesteziol Reanimatol ; 60(2): 72-6, 2015.
Article de Russe | MEDLINE | ID: mdl-26148369

RÉSUMÉ

Anticoagulant therapy with vitamin K antagonists (AVK) is an effective treatment and prevention of thrombosis. One of the major disadvantages of the AVK is a risk for serious bleeding. Prothrombin complex concentrates (PCC), fresh frozen plasma (FFP) and vitamin K1 are available for control of these situations. The experience of special team ofthe Scientific Center for Hematology was the basis for presented retrospective study. Three regimens of warfarin-related bleeding were compared: PCC+ VK for several bleeding, FFP+ VK for different clinical situations and VKfor light bleeding. PCC showed himself as effective and safe hemostatic agent. Transfusions of FFP were sometimes not effective, sometimes led to TACO. Supplementation of vitamin K1 for patients of I and II groups provided more stable control of hemostasis. In III group VK vas effective to stop bleeding. Two impotent sings for conclusion: necessary of laboratory monitoring, TEG first of all; individual balance of hemostasis base of bleeding or thrombotic risks.


Sujet(s)
Anticoagulants/effets indésirables , Hémorragie/traitement médicamenteux , Hémostatiques/usage thérapeutique , Warfarine/effets indésirables , Anticoagulants/administration et posologie , Anticoagulants/usage thérapeutique , Coagulation sanguine/effets des médicaments et des substances chimiques , Facteurs de la coagulation sanguine/administration et posologie , Facteurs de la coagulation sanguine/usage thérapeutique , Femelle , Hémorragie/sang , Hémorragie/induit chimiquement , Hémostatiques/administration et posologie , Humains , Mâle , Dossiers médicaux , Adulte d'âge moyen , Échange plasmatique , Études rétrospectives , Résultat thérapeutique , Phytoménadione/administration et posologie , Phytoménadione/usage thérapeutique , Warfarine/administration et posologie , Warfarine/usage thérapeutique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE